Ayuda
Ir al contenido

Dialnet


Moderate Hemophilia (A)

  • Autores: K.K. Sharma, G. Sahu
  • Localización: European journal of clinical pharmacy: atención farmacéutica, ISSN 2385-409X, Vol. 22, Nº. 2, 2020, págs. 106-109
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • Moderate Hemophilia A (MHA) is an unusual hemorrhagic disorder due to voluntary antibody against Anti hemophilic factor (AHF). Clinical case report on MHA with symptoms of gastrointestinal bleeding and melena. The seriousness of the disease alters according to the degree of deficiency from mild to severe mucocutaneous bleeding with spontaneous/voluntary hematomas or hemarthroses. The incidence rate is 1.0 to 1.5 cases per million population per years report at rare bleeding disorder. The HA is occasional bleeding disorder, which commonly manifests with musculocutaneous bleeding caused by autoantibody against coagulation factor VIII. The total morbidity and mortality rate 7.9-22%. A 5 years old pediatric patient presented in emergency room with complain of hematemesis and melena for 2-3 days restlessness, fever, chill, constipation, gastrointestinal bleeding. © 2020 Rasgo Editorial S.A.. All rights reserved.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno